212 related articles for article (PubMed ID: 15811254)
1. Pharmacogenetics of response to statins: where do we stand?
Maitland-van der Zee AH; Boerwinkle E
Curr Atheroscler Rep; 2005 May; 7(3):204-8. PubMed ID: 15811254
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy.
Schmitz G; Drobnik W
Clin Chem Lab Med; 2003 Apr; 41(4):581-9. PubMed ID: 12747606
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of response to statins.
Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics of cholesterol-lowering therapy.
Schmitz G; Langmann T
Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
[TBL] [Abstract][Full Text] [Related]
5. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic study of statin therapy and cholesterol reduction.
Marian AJ
Curr Atheroscler Rep; 2005 May; 7(3):177-8. PubMed ID: 15811249
[No Abstract] [Full Text] [Related]
7. Aggressive lipid therapy in the statin era.
Farmer JA
Prog Cardiovasc Dis; 1998; 41(2):71-94. PubMed ID: 9790411
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of statins therapy.
Puccetti L; Acampa M; Auteri A
Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):228-36. PubMed ID: 18221122
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of lipid-lowering response to atorvastatin therapy in an Indian population.
Kadam P; Ashavaid TF; Ponde CK; Rajani RM
J Clin Pharm Ther; 2016 Jun; 41(3):329-33. PubMed ID: 26932749
[TBL] [Abstract][Full Text] [Related]
10. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
11. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in emerging cardiovascular risk factors and response to statin therapy.
Dornbrook-Lavender KA; Pieper JA
Cardiovasc Drugs Ther; 2003 Jan; 17(1):75-82. PubMed ID: 12843689
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic importance of pravastatin.
Peters B; Maitland-van der Zee AH
Pharmacogenomics; 2008 Sep; 9(9):1207-10. PubMed ID: 18781848
[TBL] [Abstract][Full Text] [Related]
14. [Hyperlipidemia: decreasing lipid values and effects of statins].
Mathes P
Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
[No Abstract] [Full Text] [Related]
15. Resistance and intolerance to statins.
Reiner Z
Nutr Metab Cardiovasc Dis; 2014 Oct; 24(10):1057-66. PubMed ID: 24996502
[TBL] [Abstract][Full Text] [Related]
16. Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment.
Donnelly LA; van Zuydam NR; Zhou K; Tavendale R; Carr F; Maitland-van der Zee AH; Leusink M; de Boer A; Doevendans PA; Asselbergs FW; Morris AD; Pearson ER; Klungel OH; Doney AS; Palmer CN
Pharmacogenet Genomics; 2013 Oct; 23(10):518-25. PubMed ID: 23903772
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of statins in the management of atherosclerosis.
Vaughan CJ; Gotto AM; Basson CT
J Am Coll Cardiol; 2000 Jan; 35(1):1-10. PubMed ID: 10636252
[TBL] [Abstract][Full Text] [Related]
18. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
Miltiadous G; Xenophontos S; Bairaktari E; Ganotakis M; Cariolou M; Elisaf M
Pharmacogenet Genomics; 2005 Apr; 15(4):219-25. PubMed ID: 15864114
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics of lipid-lowering therapies.
Hu M; Tomlinson B
Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
[TBL] [Abstract][Full Text] [Related]
20. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
